APA

Brown J. E., McCloskey E. V., Dewar J. A., Body J. J., Cameron D. A., Harnett A. N., Ruutu M., Purohit O. P., Tähtelä R. & Coleman R. E. (20080219). The use of bone markers in a 6-week study to assess the efficacy of oral clodronate in patients with metastatic bone disease. : Calcified tissue international.

Chicago

Brown J E, McCloskey E V, Dewar J A, Body J J, Cameron D A, Harnett A N, Ruutu M, Purohit O P, Tähtelä R and Coleman R E. 20080219. The use of bone markers in a 6-week study to assess the efficacy of oral clodronate in patients with metastatic bone disease. : Calcified tissue international.

Harvard

Brown J. E., McCloskey E. V., Dewar J. A., Body J. J., Cameron D. A., Harnett A. N., Ruutu M., Purohit O. P., Tähtelä R. and Coleman R. E. (20080219). The use of bone markers in a 6-week study to assess the efficacy of oral clodronate in patients with metastatic bone disease. : Calcified tissue international.

MLA

Brown J E, McCloskey E V, Dewar J A, Body J J, Cameron D A, Harnett A N, Ruutu M, Purohit O P, Tähtelä R and Coleman R E. The use of bone markers in a 6-week study to assess the efficacy of oral clodronate in patients with metastatic bone disease. : Calcified tissue international. 20080219.